Suchergebnisse - "Tabernero, J"

PubPharm (200)

21

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer : insights from the BEACON CRC study

enthalten in: ESMO open | 2021

von Tabernero, J. | Velez, L. | Trevino, T. | +11

22

Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer : a dose-expansion, phase I study

enthalten in: ESMO open | 2021

von Bordonaro, R. | Calvo, A. | Auriemma, A. | +16

23

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer : an exploratory subgroup analysis from the TAGS study

enthalten in: ESMO open | 2021

von Tabernero, J. | Shitara, K. | Zaanan, A. | +11

24

Management of BRAF-mutant metastatic colorectal cancer : a review of treatment options and evidence-based guidelines

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Grothey, A. | Fakih, M. | Tabernero, J.

25

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

enthalten in: ESMO open | 2021

von Gyawali, B. | de Vries, E. | Dafni, U. | +20

26

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

enthalten in: ESMO open | 2021

von Garrido, P. | Adjei, A. | Bajpai, J. | +15

27

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma : phase III RESOLVE study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Tempero, M. | Oh, D. | Tabernero, J. | +16

CommentIn: Ann Oncol. 2021 May;32(5):582-583. - PMID 33607222

28

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer : A Retrospective Pooled Analysis

enthalten in: Drugs & aging | 2021

von García-Alfonso, P. | Díaz-Rubio, E. | Abad, A. | +118

29

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

30

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Serna, G. | Ruiz-Pace, F. | Hernando, J. | +11

CommentIn: Ann Oncol. 2020 Oct;31(10):1277-1278. - PMID 32629022